Home
About Us
Knowledge
Products
Business
Newsroom
Careers
Contact Us
Home
About Us
Company profile
Corporate culture
Knowledge
Drug instructions
Literature
Laws and regulations
Products
All
Drugs
Medical Devices
Health Care Product
Cosmeceuticals
Active Pharmaceutical Ingredients
Business
Newsroom
Company news
Media coverage
Careers
Employing
Recruit
Contact Us
NEWS CENTER
Home
Newsroom
Company news
Media coverage
2024.01.25
Optimizing Matters Related to the Transfer of Overseas-produced Drugs Already Marketed in China to the Marketing Registration Application of Domestic-produced Drugs (Draft for comments)
View all
2023.03.06
Notice on Requirements for Electronic Declaration of Application for drug Registration
View all
2021.09.06
Commercialization of Innovative Drugs
View all
2021.08.24
Novartis CAR-T therapy second-line treatment of B-NHL clinical study failed!
View all
2021.08.16
It's fixed! Long prescription policy to select base drugs, nationally selected Chinese drugs and medical insurance drugs
View all
2021.08.13
Centralized procurement of Chinese patent medicines and formula particles may start, starting with high-priced and large-volume varieties
View all
«
1
2
3
4
...
6
»
